Zydus lifesciences Limited

Pharmaceutical industry in India Q3 FY26 Results: India Formulations Shine as US Pricing Remains a Drag

Q3 FY26 Performance SnapshotThe Indian pharma sector delivered a steady Q3 FY26, with performance largely driven by domestic strength.Sales Growth: +13% YoYOperating Profit: +12% YoYPAT Growth: +1% YoYWhile revenue and operating profit expanded in tandem, net profit growth remained muted due to m...

Zydus Lifesciences Share Price Jumps After USFDA Nod for Bosentan; Stock Market Today Reacts

The Zydus Lifesciences share price opened higher in the stock market today after the company secured a key regulatory approval from the United States. Positive sentiment flowed in early, pushing the stock into the green as investors reacted to the development.The trigger was clear. A fresh USFDA ...

Zydus Lifesciences Q3 Results: Net Profit Stays Flat Despite Cost Pressure; Revenue Jumps 30% YoY

Market Performance SnapshotZydus Lifesciences Q3 numbers tell a familiar but important story. Strong revenue growth. Healthy operating performance. But a flat bottom line due to a one-time cost hit.For the quarter ended December, Zydus Lifesciences posted a consolidated net profit of ₹1,042 crore...

Q3 Results 2026: Over 170 Companies Set to Announce Earnings Today as Results Season Enters Key Phase | Stock Market Today

The Q3 results 2026 season is stepping into a busy stretch. As the fifth week of the December-quarter earnings unfolds, nearly 170 listed companies are scheduled to report their financial performance for the quarter ended December 31, 2025.From large-cap names to mid and small caps, today’s earni...

Nifty Indices Rejig: Status Quo Expected for Nifty 50, Action Shifts to Next 50, Midcap and Smallcap Indices

The Nifty Indices Rejig is back in focus as the National Stock Exchange (NSE) prepares for its scheduled index reshuffle. This periodic exercise often reshapes market attention, especially when new-age listings and sectoral heavyweights compete for space across benchmark and broad-market indices....

Zydus Lifescience Share Price Dips After USFDA Observations | Stock Market Today

Market PerformanceZydus Lifescience share price came under pressure in early trade on September 8. The stock slipped after the US Food and Drug Administration (USFDA) flagged four observations at the company’s Vadodara facility.At 9:25 AM, Zydus Lifescience was trading at ₹1,009.60, down ₹4.55 or...

Stock Market Today: Adani Power, SpiceJet, JP Associates, Zydus Life, Aurobindo Pharma, BHEL, HFCL, Ceigall, ACME, Prime Focus in Focus

The market is gearing up for another action-packed trading session. Several heavyweight names are in the spotlight today—driven by earnings updates, regulatory developments, partnerships, and large block deals. Let’s walk through the biggest stories shaping stock market today.Market Performance S...

Zydus Lifesciences Share Price Rises on Exclusive Licensing Deal With Synthon | Stock Market Today

Market PerformanceThe stock market today opened on a positive note for Zydus Lifesciences. The share price gained momentum in early trade, reacting to the company’s latest announcement.At 09:19 am, Zydus Lifesciences was trading at ₹1,020.00, up by ₹8.00 or 0.79% on the BSE.The move followed a fr...

Stock Market Today: Biocon, Zydus Life, Indo Tech Transformers, Bharat Forge, Yasho Industries, RPP Infra in Focus

Market PerformanceThe Indian stock market opens today with eyes on several key companies making headlines. From regulatory updates to order wins and fresh business ventures, investors are tracking developments that could shape the session’s momentum. September 5 brings a mix of corporate actions,...

Zydus Lifesciences Share Price Marginally Lower Despite Regulatory Nod from Canada

Market PerformanceThe share price of Zydus Lifesciences saw a minor dip in early trade on August 8, despite receiving a notable regulatory approval.Current Share Price: ₹942.00Change: Down ₹3.35 or 0.35% on the BSEMarket Capitalisation: ₹94,787.24 crore52-Week High: ₹1,323.90 (as on August 9, 202...

Zydus Lifesciences Share Price Rises After USFDA Approval for Celecoxib Capsules

Market PerformanceOn July 16, shares of Zydus Lifesciences opened slightly higher following a key regulatory update.Opening Price (09:19 AM): ₹973.55Price Change: Up by ₹6.40Percentage Increase: 0.66%Listing Exchange: BSEThe share movement reflected positive sentiment driven by an essential regul...

Pharma Stocks Slide: Aurobindo Pharma, Lupin, Dr Reddy’s, and Others See Sharp Decline Amid Tariff Concerns

Market PerformanceOn July 8, Indian pharmaceutical stocks experienced a notable dip in early trade as global trade tensions escalated. The Nifty Pharma index slipped nearly 1%, hovering around 22,159 during morning hours.This marked the second straight day of losses for the index, after an extend...

Pharma Stocks Buck Market Trend as Nifty Pharma Emerges Sole Gainer; Ajanta Pharma, Ipca Labs Lead Surge

Market PerformanceDespite a weak broader market on June 12, Nifty Pharma outshone as the only sectoral gainer, climbing nearly 1% to 22,243 in morning trade.This uptrend in pharma shares was primarily driven by easing global trade concerns after U.S. President Donald Trump's announcement regardin...

Nifty Pharma Index Declines Amid U.S. Tariff Announcement

Market PerformanceOn April 9, the Nifty Pharma index registered a sharp decline during early trading hours, dropping by 2 percent to 19,964.10. This continued a broader downward trend observed over the past six months, during which the index has fallen approximately 14 percent. All constituent st...